Saratov JOURNAL of Medical and Scientific Research

Critical problem of clinical pathogenicity of Helicobacter pylori in gastroen-terology

Year: 2014, volume 10 Issue: №1 Pages: 96-102
Heading: Clinical Pharmacology Article type: Review
Authors: Belova O.L., Bogoslovskaya S.I., Belova I.M.
Organization: Saratov State Medical University
Summary:

In discussional article argue unfounded of infectious hypothesis of the pathogenesis of ulceral disease of gastric and duodenum.

Bibliography:
1. Morozov IA. Helicobacter pylori was discovered in Russia in 1974. In: Marshall B. Helicobacter Pioneers: Firsthand Accounts from the Scientists Who Discovered Helicobacters. Victoria, Australia: Blackwell Science Asia, 1984; 105-118; 2. Marshall BJ. (1983). Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; 1 (8336): 1273-1275; 3. Tytgat GNJ. Helicobacter pylori: Past, present and future. J Gastroenterol Hepatol 2000; 15: Suppl G30-G33; 4. Ricci Y, Ciacci C, Zarrili R, et.al. Effect of Helicobacter pylori on gastric epitfelial cell migration and proliferation in vitro: role of VacAand CagA. Infect Immun 1996; 64 (5): 2829-2833; 5. Blazer MJ. Helicobacter pylori in human stomach. J Clin. Invest 1997; 100 (3): 759-762; 6. Blazer MJ. Helicobacter pylori and gastric diseases. Brit Med J 1998; 316 (6): 1507-1510; 7. Blazer MJ. Hipothesis: changing relationships of Helicobacter pylori and humans: implications for health and disease. J Infect Dis 1999; 79 (6): 1523-1530; 8. Lomov VM, Bardachzhyan EA. Ultrastructural foundations of the chronical gastritis. Rostov-in-Don, 1999; 240 p.; 9. Berstad АЕ, Hogasen К, Bukholm G. et al. Complement activation directly by Helicobacter pylori. Gastroenterology 2001; 120(5): 1108-1116. Клин, мед 2009; 5: 9-14; 10. Smagina NV. Peculiarities of the immunity at the men with ulceral diseasis of stomach and duodenum. JMEI 2000; 2: 57-60; 11. Nessa J, Chart H, Owen RJ, et al. Human serum antibody response to Helicobacter pylori whole cell antigen in an institutionalized Bangladeahi population. J Appl Microbiol 2001; 90(1): 68-72; 12. Andrievskaia TG, Kozlitin AV, Grigorieva EN. Combination of resistantion nonspecific of the organism at the sicks of gastritis chronic and ulceral diseasis. Rus J gastroenterol hepatol coloproctol 2001; 11 (5): Suppl 15: 14; 13. Montemurro Р, Barbuti G, Dundon WG, et al. Helicobacter [pylori neutrophil-activating protein stimulates tissue factor and plasminogen activator inhibitor-2 production by human blood mononuclear cells. J Infect Dis 2001; 183 (7): 1055-1062; 14. Appelmelk BJ, Martino MC, Veenhot E, et al. Phase variation in H tupe 1 and Lewis a epitopes of Helicobacter pylori lipopolysaccharide. Infect Immun 2000; 68 (2): 7214; 15. Rudnicka W, Czkwianianc, Planeta Malecka I, et al. A potential double role of anti-Lewis X antibodies in Helicobacter pylori-associated gastroduodenal diseases. FEMS Immunol A. Med Microbiol 2001; 30 (2): 121-125; 16. Navmar F, Roosendaal R, Kuiper EJ, et al. Present of Helicobacter pylori in the oral cavity, oesophagus, stomach and faeces of patients with gastritis. Eur J Clin Microbiol Inf Dis 1995; 14(3): 234-237; 17. Oshowo A, Gillam D, Botha A, et al. Helicobacter pylori: thr mouth, stomach, and gut axis. Ann Periodontol 1998; 3 (1): 276-280; 18. Eslik GD. Helicobacter pylori infection transmited sexually via oral-genital contact: a hypothetical model. Sex Transmit Inf 2000; 76 (6): 489-492; 19. Zhebrun AB. Infection of Helicobacter pylori. SPb., 2006; 380 p. Russian (Жебрун АБ. Инфекция Helicobacter pylori. СПб., 2006; 380 c.; 20. Svarval AV, Ferman RS, Zhebrun AB. Analisis of prevalensity of infection of Helicobacter pylori among of children in modern period. JMEI 2012; 1: 83-88; 21. Zymerman YaS. Gastroduodenal diseases and Helicobacter pylori-infections: common review of problem. Clin med 2009; 5: 9-14; 22. Zymerman YaS. Eubiosis and disbiosis of gastrointestinal highway: myths and reality. Clin med 3013; 1: 4-11; 23. Sadovnikova NU. Infection of bacteriae of genus Helicobacter at dogs: diagnostical, microbiological and pathological aspects: PhD abstract. M., 2001; 20 p.; 24. Vaira D, Valik N. Blood, urine, stool, breath, money and Helicobacter pylori. Gut 2001; 48 (3): 287-289; 25. Hermanns W, Smith K, Breuer W, et al. Helicobacter-like organisms: histopathological examination of gastric biopsies from dpgs and cats. J Comparative Pathol 1995; 112 (2): 307-318; 26. Simpson KW, Burrows CF. Гастриты, язвы и бактерии Helicobacter pylori spp. у людей, собак и кошек. Walham Focus 1997; 7(3): 2-6; 27. Korobov AV. Significans of Helicobacter pylori in pathogenesisofthe ulceral disease of stomach of hog. Veterinary 1999; 6: 41-42. Russian (Коробов AB Значение Helicobacter pylori в патогенезе язвенной болезни желудка свиней. Ветеринария 1999; 6: 41-42; 28. Salama NR, Otto G, Tompkins L, Falkow S. Vacuolating cytotoxin of Helicobacter pylori plays a role during colonization in a mous model infection. Infect Immun 2001; 69 (2): 69730-69736; 29. Palframan SL, Kwok T, Gabriel K. Vacuolating cytotoxin A (VacA), a key toxin for Helicobacter pylori pathogenesis. Front Cell Infect Microbiol 2012; 2 (2): 131 -138; 30. Cover TL, Blanke SR. Helicobacter pylori vacA, a paradigm for toxin multifunctionality. Gastroenterology 2009; 136 (6): 1863-1873; 31. Ginisset Ch.Galeotti CL, Lupetti P, et al. A Helicobacter pylori vacuolating toxin mutant that fails to oligomerize has a dominant negative phenotype. Infect Immun 2006; 74 (3): 1786-1794; 32. Relman A (2010) The human indigenous microbiota. Henry Stewart Talks. http://hstalks.com/main/view-talks php?t=1482&r=609&j=756&c=252; 33. Finlay BB (2011) Introduction to microbiota: agents for health and diseases. Henry Stewart Talks, http://hstalks.com/ main/view-talks php?t=2092&r=609&j =252; 34. Brands-Heerma S, van Vliet AHM, Kuipers EJ, et al. Genomic changes in Helicobacter pylori during chronic infection. Gut 2000; 47(1): 18; 35. Israel DA, Sakama N, Arnold CN, et al. Helicobacter pylori strein-specific differences in genetic content, identified by microarray, influence host inflammatory responses. J Clinic Invest 2001; 107 (5): 611-620; 36. Covacci A (2007) From CagA to CagA: the metamorphoses of the Helicobacter pylori cytotoxin-associated gene A into the camcer-associated gene A. Henry Stewart Talks. http://htalks.cjm/main/view-talks.php?t=1715&r=441 &-j=760&c=252; 37. Ricci V, Romano M, Boquet P. Molecular cross-talk between Helicobacter pylori and human gastric mucosa. World J Gastroenterol2011; 11: 1383-1399; 38. Axon A (2011) Gastric cancer, gastritis and the role Helicobacter pylori. Henry Stewart Talks, http://hstalks.com/main/ view-talks php?t=1905&r=532&j=756&c=252; 39. Belova OL. Significans of Helicobacter pylori and his cagA-genotype in pathogenesis gastroduodenal disease and pharmacotherapy of ulceral disease: PhD diss. Saratov, 2003; 139 p.; 40. Volkov VS, Kolesnikova IU, Belayeva GS, et al. What promote convert Helicobacter pylori out of symbionte in ethiopathgenetic factor ulceral disease of duodenum? Experim din gastroenterology 2010; 32: 48-52; 41. Bucharin OV, Lobanov ES, Perunov NB, Usvaycov BYa, Cherkasov SV. Symbiosis and his role in infection. Ekaterinburg, 2011; 300 p.; 42. CherninVV, BondarenkoVM,ChervinecVM,BazlovSN. The siat Helicobacter pylori in normobiocenosisand disbacteriosis of microflorae mucosis of the ezophagogastroduodenal zone in his inflammatorial erosio-ulceral defeats. Therap archiv 2012; 84 (2): 10-16; 43. Blinkov IL. Problem of Helicobacter pylori: myth and reality. Clin med 1997; 12: 71-74. Russian (Блинков И. Л. Проблема Helicobacter pylori: миф и реальность. Клин. мед. 1997; 12:71-74); 44. Krilov NN. Problems which поп can be agitated: Utopias and realities of modern teaching about of ulceral disease. Herald surg gastroenterology 2007; 31: 25-30; 45. Ivashkin VT, Lapina TL. Significans of molecule of adgesiae in pathogenesis of the infection Helicobacter pylori. Ras J gastroenterol hepatol & coloproctol 1997; 7 (6): 20-27; 46. Heczko U, Smith VC Moleche RM.etal. Characteristics of Helicobacter pylori attachement to human primary antral epithelial cells. Microbes & Immun 2000; 2 (14): 1669-1676; 47. Minushkin ON, Zverkov IV. Exponents of acidital production (AP), levels pepsinogene 1 (LP1), gastrine (G) and somatostatine (SS) in blood, gastroduodenal C- and D-cells in ulceral disease (UD) of stomach, associated and nonassociated with Helicobacter pylori (HP). Rus J gastroenterol hepatol coloproctol 2001; 11 (5) Suppl: 15-54; 48. Konturek Р, Rembiarz К, Hahn EG, et al. Helicobacter pylori and impaired gastric secretory functions associated with duodenal ulcer and atrophic gastritis. J Phisiol Pharmacol 1997; 48 (2): 365-373; 49. Peterson WL. Gastrin and acid in relation to Helicobacter pylori. Aliment Pharmacol Therap 1996; 10 Suppl 1: 97-102; 50. Zymerman YaS. Ulceral disease: actual problems of the etiology, pathogenesis, differential thrapy. Clin med 2012; 8: 11-18; 51. Zukanov VV, Shtigasheva OV, Barkalov SB. Helicobacter pylori and ulceral disease in popylation of Chakassia. Therap arciv 1999; 71 (2): 17-19; 52. Kuchtevich AV, Bolotova OV, Zilov VG. Steam of ulceral disease in dependence from constitutional peculiarities of the ills. Clin med 2001; 5: 41-44; 53. Aruin LI, Kapuller LL, Isakov VA. Morphological diagnostic diseases of stomach and intestinum. Moscow. 1998; 496 p.; 54. McColl KEL. Helicobacter pylori, gastric acid and duodenal gastric metaplasia. Gut 1996; 39 (2): 615-616; 55. Bechi P, Balzi V, Beccolini A, et al. Helicobacter pylori and cell proliferation. Amer J Gastroenterol 1996; 91 (1): 271-276; 56. Murakami K, Fujioka T, Kodama R, et al. Helicobacter pylori infection accelerates human gastric mucosal cell proliferation. J Gastroenterol 1997; 32 (1): 184-188; 57. Peek RM, Moss SF, Tham KT, et al. Helicobacter pylori cagA+ straining and dissociation of gastric epithelial cell proliferation from apoptosis. J Natl Cancer Inst 1997; 89 (3): 863-868; 58. Rokkas MP, Lodas S, Liatsos C, et al. Relationship of Helicobacter pylori CagA status on gastric cell proliferation and apoptosis. Dig Dis Sci 1999; 44 (2): 487-493; 59. Hong SJ, Helander HF Hipergastrinemia increases proliferation of gastroduodenal epithelium. Dig Dis Sci 1996; 41 (1:) 40-48; 60. Aruin LI. Apoptosis in pathological process in organs of digestion. Clin med 2000; 1: 5-10. Russian (Аруин Л. И. Апоптоз при патологических процессах в органах пищеварения. Клин. Мед. 2000; 1:5-10); 61. Houghton J, Korah RM, Cordon MR, et al. Apoptosis in Helicobacter pylori associeted gastric and duodenal ulcer disease is mediated via the Fas antigen pathway. Dig Dis Sci 1999; 44 (2): 465-478; 62. Igarashi M, Katada Y, Yoshiyama H, et al. Ammonia as an accererator of tumor necrosis factor alpha-induced apoptosis of gastric epithelial cells in Helicobacter pylori infection. Infect Immun2001;69(2):816-821; 63. Piotrowski J. Induction of gastritis and epithelial apoptosis by Helicobacter pylori lipopolysaccharide. Scand J Gastroenterol 1997; 32 (1): 203-211; 64. Reinacher-Schick A, Petrach S, Burger A, et al. Helicobacter pylori induced apoptosis in mucosal lymphocytes in patients with gastritis. Z Gastroenterol 1998; 36 (4): 1021-1026; 65. Rudi J, Kuck DD, von Herbay AP, et al. Helicobacter pylori induced apoptosis in mediated by the CD 95 (FAS) receptor and ligand system. Gut 1998; 43(1): 14; 66. Pavlovich IM, Gordienko AV, Sidorenko VA, Leichincki SV. The influence of eradication Helicobacter pylori in morphological structure mucous membrane of stomach in patients with chronicai gastritis. Herald modern clin med 2012; 5 (Suppl):85-88; 67. BlaserM Antibiotic overuse: stop the killing of beneficial bacteria. Nature 2011; 476 (7361): 393-394; 68. Ceneva GYa, Ruchlyada NV, Nazarov VE, Popov EA, Zhebrun AB. Pathogenesis, diagnosis and therapia of infection Helicobacter pylori. SPb., 2003; 96 p.

AttachmentSize
2014_01_96-102.pdf565.75 KB

No votes yet